Skip to main content
PolicySpeak
← All files
UMC

University Medical Center Groningen

Academic / research · Netherlands · EU Transparency Register 021901530468-42

2
positions filed
in the 326 files tracked
2
legislative files
of 326 tracked
0
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.

Who they are

Among the 126 think tanks and research institutions on this site, they rank #72 by legislative files engaged — a count of participation, not a measure of influence.

3.2
declared lobbying FTE
self-declared
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2018
in the register since

Declares membership of

  • EIT Health - https://eithealth.eu/
  • ERN EURACAN - https://euracan.eu/
  • MetabERN - https://metab.ern-net.eu/
  • ERKNet - https://www.erknet.org/
  • ENLIGHT - https://enlight-eu.org/
  • The Guild - https://www.the-guild.eu/
  • Coimbra Group - https://www.coimbra-group.eu/

Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).

Register category
Think tanks and research institutions
Registered as
University Medical Center Groningen/Academisch Ziekenhuis Groningen (UMCG)
Head office
Groningen, Netherlands

Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.

Track University in PolicySpeak: request access →

Work at University Medical Center Groningen? so we know who speaks for it.

Follow the files University Medical Center Groningen engages with

One email on Tuesdays when a new position is filed on these 2 files, from University Medical Center Groningen or from anyone else on them. Only when there is something new.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Their record over time

University Medical Center Groningen filed 2 positions between 9 Sept 2025 and 2 Oct 2025, across 2 of the 326 legislative files tracked here.

What they argued

European Innovation Actfiled 2 Oct 2025source

The University Medical Center Groningen (UMCG) is a university hospital with strong clinical research and testing infrastructure, an active valorisation chain (TTO, spin-offs), and intensive public-private collaboration. From this position, we support a European Innovation Act (EIA) that removes practical bottlenecks for health innovation and accelerates the path from lab to clinic and market.

European Research Area (ERA) Actfiled 9 Sept 2025source

The University Medical Center Groningen (UMCG) welcomes the European Commissions initiative to prepare a legislative proposal for an ERA Act. With regard to the Call for Evidence: R&D investment target: UMCG supports achieving the 3% R&D investment target but emphasizes that this must not come at the expense of basic or clinical research, nor result in disproportionate emphasis on defense-related R&D.

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Turns up on the same files

Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.

Showing 5 of 27.

Is this your organization?

Everything on this page comes from University Medical Center Groningen’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.